Seeking Alpha

Accretive Health (AH +4.1%) outperforms after UBS starts the company at Outperoform. The firm...

Accretive Health (AH +4.1%) outperforms after UBS starts the company at Outperoform. The firm touts the ability of Accretive's revenue management services to improve hospital margins, and sees its penetration rate rising to 5% by 2014, from a current 2%. UBS also believes new services offerings are ramping ahead of expectations.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector